FILINGS
| DVAX 0001029142 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2013-05-30 | 8-K | ANNUAL MEETING | View Document |
| 2013-05-30 | UPLOAD | View Document | |
| 2013-05-09 | 10-Q | FORM 10-Q | View Document |
| 2013-05-06 | 8-K | 8-K | View Document |
| 2013-05-03 | 8-K | FORM 8-K | View Document |
| 2013-05-03 | 4 | FORM 4 | View Document |
| 2013-05-03 | 4 | View Document | |
| 2013-05-03 | 3 | FORM 3 | View Document |
| 2013-04-29 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2013-04-17 | PRE 14A | PRELIMINARY PROXY STATEMENT | View Document |
| 2013-04-04 | 8-K/A | 8-K/A | View Document |
| 2013-03-29 | 8-K | FORM 8-K | View Document |
| 2013-03-29 | 424B5 | FILED PURSUANT TO RULE 424(B)(5) | View Document |
| 2013-03-27 | 4 | View Document | |
| 2013-03-27 | 3 | View Document | |
| 2013-03-21 | 8-K | View Document | |
| 2013-03-08 | 10-K | FORM 10-K | View Document |
| 2013-03-01 | 8-K | 8-K | View Document |
| 2013-03-01 | 8-K | FORM 8-K | View Document |
| 2013-02-26 | 8-K | 8-K | View Document |
| 2013-02-25 | 8-K | 8-K HEPLISAV(TM) CRL | View Document |
| 2013-02-14 | SC 13G/A | AMENDMENT #1 | View Document |
| 2013-02-14 | SC 13G/A | View Document | |
| 2013-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2013-02-12 | SC 13G | View Document | |
| 2013-02-12 | SC 13G/A | View Document | |
| 2013-02-11 | SC 13G | View Document | |
| 2013-02-07 | 4 | FORM 4 | View Document |
| 2013-02-07 | 4 | FORM 4 | View Document |
| 2013-02-07 | 4 | FORM 4 | View Document |
| 2013-02-07 | 4 | FORM 4 | View Document |
| 2013-02-07 | 8-K | FORM 8-K | View Document |
| 2013-02-05 | 8-K | 8-K | View Document |
| 2013-01-17 | 4 | View Document | |
| 2012-12-19 | 8-K | 8-K | View Document |
| 2012-12-19 | 4 | FORM 4 | View Document |
| 2012-11-21 | SC 13G | SC 13G | View Document |
| 2012-11-19 | 4 | FORM 4 | View Document |
| 2012-11-15 | 8-K | FORM 8-K | View Document |
| 2012-11-07 | 4 | COFFMAN 10B5-1 | View Document |
| 2012-11-02 | 8-K | FORM 8-K 11-2-2012 | View Document |
| 2012-11-02 | 10-Q | FORM 10-Q | View Document |
| 2012-11-02 | 8-K | DYNAVAX REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS | View Document |
| 2012-11-01 | 8-K | DYNAVAX TO INITIATE PHASE 1 STUDY FOR ASTHMA | View Document |
| 2012-10-17 | 4 | 4 | View Document |
| 2012-10-17 | SC 13D/A | SC 13D/A | View Document |
| 2012-10-09 | 4 | COFFMAN 10B5-1 SALE | View Document |
| 2012-10-04 | 4 | STEPHEN TUCK PERFORMANCE AWARD RSU | View Document |
| 2012-09-14 | 4 | LEW OPTION EXERCISE | View Document |
| 2012-09-14 | 4 | COFFMAN 10B5-1 SALE | View Document |
| 2012-09-06 | 4 | COFFMAN 10B5-1 SALE | View Document |
| 2012-08-28 | 8-K | DYNAVAX ANNOUNCES FDA ADVISORY COMMITTEE TO REVIEW HEPLISAV | View Document |
| 2012-08-23 | 8-K | MAA ACCEPTANCE | View Document |
| 2012-08-15 | 8-K | CHRISTINE R. LARSON APPOINTED AS CFO | View Document |
| 2012-08-14 | CT ORDER | View Document | |
| 2012-08-14 | 4 | ISSANCE OF STOCK OPTIONS | View Document |
| 2012-08-14 | 3 | LARSON INITIAL HOLDINGS | View Document |
| 2012-08-03 | 10-Q | FORM 10-Q | View Document |
| 2012-08-01 | 8-K | DYNAVAX REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS | View Document |
| 2012-07-24 | 8-K | DYNAVAX SUBMITS HEPLISAV(TM) FOR EU MARKETING AUTHORIZATION | View Document |
| 2012-06-26 | 8-K | 8-K | View Document |
| 2012-06-21 | 4 | FORM 4 | View Document |
| 2012-06-01 | 8-K | 8-K | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-31 | 4 | FORM 4 | View Document |
| 2012-05-10 | 8-K | FORM 8-K | View Document |
| 2012-05-10 | 424B5 | FILED PURSUANT TO RULE 424(B)(5) | View Document |
| 2012-05-10 | 424B5 | FILED PURSUANT TO RULE 424(B)(5) | View Document |
| 2012-05-08 | 424B5 | FILED PURSUANT TO RULE 424(B)(5) | View Document |
| 2012-05-08 | 424B5 | FILED PURSUANT TO RULE 424(B)(5) | View Document |
| 2012-05-08 | 8-K | FORM 8-K | View Document |
| 2012-05-04 | 10-Q | QUARTERLY REPORT ON FORM 10-Q | View Document |
| 2012-05-03 | 4 | FORM 4 | View Document |
| 2012-05-03 | 4 | FORM 4 | View Document |
| 2012-04-30 | 8-K | 8-K | View Document |
| 2012-04-26 | 8-K | 8-K | View Document |
| 2012-04-25 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2012-04-11 | SC 13G/A | View Document | |
| 2012-04-10 | CT ORDER | View Document | |
| 2012-03-28 | 8-K | 8-K | View Document |
| 2012-03-15 | 4 | 2012 RSU GRANT | View Document |
| 2012-03-14 | 8-K | 8-K | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
| 2012-03-12 | 4 | FORM 4 | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
